Tower Research Capital (TRC)’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27K | Buy |
23,310
+9,794
| +72% | +$11.4K | ﹤0.01% | 3483 |
|
|
2025
Q1 | $18.2K | Buy |
13,516
+11,871
| +722% | +$16K | ﹤0.01% | 3056 |
|
|
2024
Q4 | $21.7K | Sell |
1,645
-84
| -5% | -$1.11K | ﹤0.01% | 3125 |
|
|
2024
Q3 | $19.4K | Sell |
1,729
-5,960
| -78% | -$66.8K | ﹤0.01% | 3253 |
|
|
2024
Q2 | $82.7K | Buy |
7,689
+6,979
| +983% | +$75K | ﹤0.01% | 2717 |
|
|
2024
Q1 | $10.6K | Sell |
710
-13,733
| -95% | -$205K | ﹤0.01% | 3682 |
|
|
2023
Q4 | $262K | Buy |
14,443
+5,273
| +58% | +$95.5K | ﹤0.01% | 1881 |
|
|
2023
Q3 | $159K | Buy |
9,170
+6,721
| +274% | +$117K | 0.01% | 1606 |
|
|
2023
Q2 | $44.4K | Buy |
2,449
+1,790
| +272% | +$32.4K | ﹤0.01% | 2651 |
|
|
2023
Q1 | $17K | Sell |
659
-976
| -60% | -$25.2K | ﹤0.01% | 3644 |
|
|
2022
Q4 | $32K | Sell |
1,635
-3,777
| -70% | -$73.9K | ﹤0.01% | 2693 |
|
|
2022
Q3 | $113K | Buy |
5,412
+2,289
| +73% | +$47.8K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $25K | Buy |
3,123
+853
| +38% | +$6.83K | ﹤0.01% | 3569 |
|
|
2022
Q1 | $16K | Buy |
2,270
+640
| +39% | +$4.51K | ﹤0.01% | 3765 |
|
|
2021
Q4 | $22K | Buy |
1,630
+923
| +131% | +$12.5K | ﹤0.01% | 3569 |
|
|
2021
Q3 | $11K | Sell |
707
-884
| -56% | -$13.8K | ﹤0.01% | 4246 |
|
|
2021
Q2 | $46K | Buy |
1,591
+34
| +2% | +$983 | ﹤0.01% | 3091 |
|
|
2021
Q1 | $61K | Buy |
1,557
+305
| +24% | +$11.9K | ﹤0.01% | 2959 |
|
|
2020
Q4 | $29K | Sell |
1,252
-3,173
| -72% | -$73.5K | ﹤0.01% | 3601 |
|
|
2020
Q3 | $100K | Buy |
+4,425
| New | +$100K | ﹤0.01% | 3146 |
|